ATE210145T1 - Neue kationische cholesterin derivate mit zyklischen polaren gruppen - Google Patents

Neue kationische cholesterin derivate mit zyklischen polaren gruppen

Info

Publication number
ATE210145T1
ATE210145T1 AT97920357T AT97920357T ATE210145T1 AT E210145 T1 ATE210145 T1 AT E210145T1 AT 97920357 T AT97920357 T AT 97920357T AT 97920357 T AT97920357 T AT 97920357T AT E210145 T1 ATE210145 T1 AT E210145T1
Authority
AT
Austria
Prior art keywords
polar groups
cholesterol derivatives
new cationic
cationic cholesterol
cyclic polar
Prior art date
Application number
AT97920357T
Other languages
English (en)
Inventor
Hemant M Deshmukh
Leaf Huang
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE210145T1 publication Critical patent/ATE210145T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97920357T 1996-04-12 1997-04-11 Neue kationische cholesterin derivate mit zyklischen polaren gruppen ATE210145T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63120396A 1996-04-12 1996-04-12
PCT/US1997/006066 WO1997039019A1 (en) 1996-04-12 1997-04-11 Novel cationic cholesteryl derivatives containing cyclic polar groups

Publications (1)

Publication Number Publication Date
ATE210145T1 true ATE210145T1 (de) 2001-12-15

Family

ID=24530212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920357T ATE210145T1 (de) 1996-04-12 1997-04-11 Neue kationische cholesterin derivate mit zyklischen polaren gruppen

Country Status (8)

Country Link
US (1) US6927213B2 (de)
EP (1) EP0904282B1 (de)
AT (1) ATE210145T1 (de)
CA (1) CA2251543A1 (de)
DE (1) DE69708868T2 (de)
DK (1) DK0904282T3 (de)
ES (1) ES2165050T3 (de)
WO (1) WO1997039019A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
EP0910343A1 (de) 1996-07-03 1999-04-28 University Of Pittsburgh Emulsionsformulierungen für hydrophile wirkstoffe
US5925628A (en) * 1997-03-31 1999-07-20 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5912239A (en) * 1997-04-04 1999-06-15 Genzyme Corporation Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
US5948925A (en) * 1997-05-06 1999-09-07 Genzyme Corporation Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
US5952516A (en) * 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
US5942634A (en) * 1997-05-09 1999-08-24 Genzyme Corporation Cationic amphiphiles for cell transfections
GB0015624D0 (en) * 2000-06-26 2000-08-16 Nat Cancer Centre Materials and methods relating to improved gene delivery
GB2372502B (en) * 2000-12-12 2004-10-13 Imperial College Carbohydrate compounds containing cholesterol and their use
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
DE10109898A1 (de) 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
US7858117B2 (en) 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
CA2724408A1 (en) * 2008-05-19 2009-11-26 The University Of North Carolina At Chapel Hill Methods and compositions comprising novel cationic lipids

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE589491A (de) * 1959-04-10
US3459766A (en) 1965-03-12 1969-08-05 Du Pont 2,2,5,5-tetrakis(polyfluoromethyl)imidazolidines and their preparation
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4958013A (en) 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
US5100662A (en) 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5676954A (en) 1989-11-03 1997-10-14 Vanderbilt University Method of in vivo delivery of functioning foreign genes
WO1993003709A1 (en) 1991-08-16 1993-03-04 Vical, Inc. Composition and method for treating cystic fibrosis
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
JP2990624B2 (ja) * 1991-10-21 1999-12-13 味の素株式会社 油溶性ｎ−長鎖アシル中性アミノ酸エステル及びそれらを含む香粧品及び外用医薬基剤
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
WO1993024640A2 (en) 1992-06-04 1993-12-09 The Regents Of The University Of California Methods and compositions for in vivo gene therapy
US5646126A (en) 1994-02-28 1997-07-08 Epoch Pharmaceuticals Sterol modified oligonucleotide duplexes having anticancer activity
CA2186118C (en) 1994-03-23 2010-10-19 Richard W. Hanson Compacted nucleic acids and their delivery to cells
US6077835A (en) 1994-03-23 2000-06-20 Case Western Reserve University Delivery of compacted nucleic acid to cells
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5635487A (en) 1994-12-29 1997-06-03 Wolff; Jon A. Amphipathic, micellar delivery systems for biologically active polyions
US6008202A (en) 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
GB9515356D0 (en) 1995-07-26 1995-09-20 Medical Res Council Improvements in or relating to delivery of nucleic acid
WO1997004748A2 (en) * 1995-08-01 1997-02-13 Advanced Therapies, Inc. Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
EP0910343A1 (de) 1996-07-03 1999-04-28 University Of Pittsburgh Emulsionsformulierungen für hydrophile wirkstoffe
CA2264140A1 (en) 1996-08-26 1998-03-05 Transgene S.A. Cationic lipid-nucleic acid complexes
US6271209B1 (en) 1998-04-03 2001-08-07 Valentis, Inc. Cationic lipid formulation delivering nucleic acid to peritoneal tumors

Also Published As

Publication number Publication date
EP0904282B1 (de) 2001-12-05
DE69708868D1 (de) 2002-01-17
DK0904282T3 (da) 2002-03-04
ES2165050T3 (es) 2002-03-01
WO1997039019A1 (en) 1997-10-23
DE69708868T2 (de) 2002-07-18
US20030203871A1 (en) 2003-10-30
US6927213B2 (en) 2005-08-09
CA2251543A1 (en) 1997-10-23
EP0904282A1 (de) 1999-03-31
AU2457397A (en) 1997-11-07
AU715376B2 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
DE69708868D1 (de) Neue kationische cholesterin derivate mit zyklischen polaren gruppen
CU23048A3 (es) Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE3581992D1 (de) Milchsaeurederivat, dieses enthaltende fluessigkristallkomposition und fluessigkristalleinrichtung.
FR2678615B1 (fr) Benzofuranne-2-ones thiomethylees, leur preparation et leur application comme stabilisants de matieres organiques.
DE69730218D1 (de) Fusogene liposomen
FI970810A (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
DE69831589D1 (de) Zusammenfügung von knorpelmatrizen unter verwendung isolierter chondrozyten
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
ES2132253T3 (es) Lipidos cationicos.
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
CO5271726A1 (es) Composicion farmaceutica soluble en agua en un complejo ionico y el uso de la misma
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
DK0767798T3 (da) Sterolderivater anvendt til regulering af meiose
ES2117426T3 (es) Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
FI990134A0 (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
UA26431A (uk) Похідhі сиh-ізомеру цефалоспориhу, їх оптичhо активhі аhтиподи або рацемічhа суміш, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі
FR2567884B1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
DE60031663D1 (de) Flammschutzmittel, verfahren zu dessen herstellung und flammschutzmittelharzzusammensetzung dieses enthaltend
DE59804752D1 (de) Herstellung von Perylen-3,4-dicarbonsäureanhydriden
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
DE3750271D1 (de) Substituierte Thiacycloalkeno [3,2-b] pyridine, Methode zur Herstellung, Zubereitungen und Methode zu ihrer Anwendung.
DE69812438T2 (de) Zusammensetzung zur herstellung von brennstoff-briketts
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee